FDA Pilot Program Shortens Drug Reviews; ‘We Have Got to Modernize the Agency,’ Makary Says at BIO
To be eligible for the FDA’s new Commissioner’s National Priority Voucher program, a drug must meet certain national health interests. Qualifying medicines could be reviewed in one to two months, down from the standard 10 months to a year.